Search for content and authors
 

dr Zofia Mazerska

e-mail:
phone: +48-58-3472407
fax: +48-58-3471516
web:
interest(s):

Affiliation:


Department of Pharmaceutical Technology and Biochemistry, Gdansk University of Technology

address: Narutowicza St 11/12, Gdańsk, 80-233, Poland
phone:
fax:
web:

Participant:


V Multidyscyplinarna Konferencja Nauki o Leku

began: 2006-05-15
ended: 2006-05-17
Presented:

V Multidyscyplinarna Konferencja Nauki o Leku

METABOLIC TRANSFORMATIONS OF ANTITUMOR AGENTS WITH CYTOCHROME P-450 ISOENZYMES.

Participant:


Zjazd Polskiego Towarzystwa Biochemicznego

began: 2007-09-18
ended: 2007-09-21
Presented:

Zjazd Polskiego Towarzystwa Biochemicznego

Metabolic transformations of antitumor agents with cytochrome P-450 isoenzymes

Participant:


VI Multidyscyplinarna Konferencja Nauki o Leku

began: 2008-05-25
ended: 2008-05-29
Presented:

VI Multidyscyplinarna Konferencja Nauki o Leku

The role of hepatic cytochrome P-450 enzymes in metabolism of imidazoacridinone antitumor agent, C1311 (SymadexR): studies with the hepatic NADPH:cytochrome P450 reductase null mice

VI Multidyscyplinarna Konferencja Nauki o Leku

Specific metabolism of antitumor agents with cytochrome P-450 isoenzymes

Participant:


VII Multidyscyplinarna Konferencja Nauki o Leku

began: 2010-05-09
ended: 2010-05-13
Presented:

VII Multidyscyplinarna Konferencja Nauki o Leku

Polymorphism and the level of P450 gene expression in drug metabolism

Participant:


IX Multidyscyplinarna Konferencja Nauki o Leku

began: 2014-05-11
ended: 2014-05-15
Presented:

IX Multidyscyplinarna Konferencja Nauki o Leku

Glucuronidation of antitumor agents - detoxification, mechanism of drug resistance or the prodrug design? Studies on acridine antitumor agents in the light of clinical therapeutics

Publications:


  1. Glucuronidation of antitumor agents - detoxification, mechanism of drug resistance or the prodrug design? Studies on acridine antitumor agents in the light of clinical therapeutics
  2. Imidazoacridinone antitumor agent, C-1311, as a selective mechanism-based inactivator of human recombinant cytochrome P450 1A2.
  3. Metabolic transformations of antitumor agents with cytochrome P-450 isoenzymes
  4. METABOLIC TRANSFORMATIONS OF ANTITUMOR AGENTS WITH CYTOCHROME P-450 ISOENZYMES.
  5. Metabolism of antitumor 9-amino-1-nitroacridine derivative C-1748 (Capridine-beta) in human hepatoma HepG2 cells
  6. Polymorphism and the level of P450 gene expression in drug metabolism
  7. Specific metabolism of antitumor agents with cytochrome P-450 isoenzymes
  8. The role of Cytochrome P450 Reductase in metabolism of potent nitroacridine antitumor agent, C‑1748.
  9. The role of hepatic cytochrome P-450 enzymes in metabolism of imidazoacridinone antitumor agent, C1311 (SymadexR): studies with the hepatic NADPH:cytochrome P450 reductase null mice



Google
 
Web science24.com
© 1998-2024 pielaszek research, all rights reserved Powered by the Conference Engine